" /> Recent investigations suggest that ADB-Butinaca, a synthetic cannabinoid, may leave a detectable residue in the urine, presenting a potential opportunity for design of a sensitive diagnostic method. Still, extensive evaluation is critical to establish its clinical performance and rule out erro